Shakta M. Satyam

Ras Al-khaimah, RK, United Arab Emirates

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications

Tumoral Metabolism at the Intersection of Oncogene Signaling, Epigenetics and Immunology: Emerging Therapeutic Strategies in Cancer.

Tumoral Metabolism at the Intersection of Oncogene Signaling, Epigenetics and Immunology: Emerging Therapeutic Strategies in Cancer.

Journal: Current issues in molecular biology
Published: June 06, 2026

Metformin as a Metabolic Reprogramming Interface in Host-Pathogen and Bone Microenvironment Crosstalk: A Dual-Target Strategy Against Antimicrobial Resistance and Osteoporotic Bone Loss.

Metformin as a Metabolic Reprogramming Interface in Host-Pathogen and Bone Microenvironment Crosstalk: A Dual-Target Strategy Against Antimicrobial Resistance and Osteoporotic Bone Loss.

Journal: Antibiotics (Basel, Switzerland)
Published: May 03, 2026

Pharmacogenomics and Epigenetic Regulation Transforming Pediatric Precision Therapeutics.

Pharmacogenomics and Epigenetic Regulation Transforming Pediatric Precision Therapeutics.

Journal: Journal of personalized medicine
Published: April 28, 2026

Adenosine Signaling as a Central Integrative Network in Cellular Stress Responses and a Therapeutically Actionable Target in Human Disease.

Adenosine Signaling as a Central Integrative Network in Cellular Stress Responses and a Therapeutically Actionable Target in Human Disease.

Journal: Biomolecules
Published: March 13, 2026

Intelligent therapeutic robotic-assisted surgery as the next frontier of precision oncology.

Intelligent therapeutic robotic-assisted surgery as the next frontier of precision oncology.

Journal: Frontiers in oncology
Published: March 08, 2026

A cost-effective proof-of-concept ex vivo perfusion model for myocardial ischemia-reperfusion injury in wistar rats: enhancing accessibility in resource-constrained settings.

A cost-effective proof-of-concept ex vivo perfusion model for myocardial ischemia-reperfusion injury in wistar rats: enhancing accessibility in resource-constrained settings.

Journal: Frontiers in cardiovascular medicine
Published: March 01, 2026

Correction: Redefining pancreatogenic diabetes mellitus through molecular, imaging, and AI-driven evidence.

Correction: Redefining pancreatogenic diabetes mellitus through molecular, imaging, and AI-driven evidence.

Journal: Frontiers in endocrinology
Published: February 16, 2026

Pimozide Reprograms the Ran GTPase-SCF Axis and Matrix Remodeling Pathways in Breast, Colorectal, and Pancreatic Cancer Models.

Pimozide Reprograms the Ran GTPase-SCF Axis and Matrix Remodeling Pathways in Breast, Colorectal, and Pancreatic Cancer Models.

Journal: Cancers
Published: January 20, 2026

Repurposing mebendazole to reprogram oncogenic and tumor-suppressor networks: Multi-cancer insights from ENOX2, MMP2, RASSF1A, WFDC10A and METTL7A.

Repurposing mebendazole to reprogram oncogenic and tumor-suppressor networks: Multi-cancer insights from ENOX2, MMP2, RASSF1A, WFDC10A and METTL7A.

Journal: PloS one
Published: January 13, 2026

Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials.

Natural products as kinase inhibitors in lung cancer: molecular mechanisms, therapeutic potential, and clinical trials.

Journal: Frontiers in pharmacology
Published: December 10, 2025

Chronopharmacology-Driven Precision Therapies for Time-Optimized Cardiometabolic Disease Management.

Chronopharmacology-Driven Precision Therapies for Time-Optimized Cardiometabolic Disease Management.

Journal: Biology
Published: December 03, 2025

COVID-19 vaccination remains essential for healthcare professionals: clinical evidence from a Polish cross-sectional study.

COVID-19 vaccination remains essential for healthcare professionals: clinical evidence from a Polish cross-sectional study.

Journal: Frontiers in public health
Published: November 20, 2025
Showing 1-12 of 46

Last Updated: 09/26/2026